A case of toxic epidermal necrolysis with extensive intestinal involvement by Keiko Nishimura et al.
POSTER PRESENTATION Open Access
A case of toxic epidermal necrolysis with
extensive intestinal involvement
Keiko Nishimura1*, Riichiro Abe1, Makiko Yamaguchi1, Takamasa Ito1, Shinichi Nakazato1, Youhei Hamade1,
Nao Saito1, Reine Moriuchi1, Takehiko Katsurada2, Mika Watanabe3, Maroto Maria Iitani3, Hiroshi Shimizu1
From 6th Drug Hypersensitivity Meeting (DHM 6)
Bern, Switzerland. 9-12 April 2014
Toxic epidermal necrolysis (TEN) is life-threatening cuta-
neous adverse drug reaction characterized by extensive
keratinocyte death. Gastrointestinal (GI) involvement in
TEN is rare, however it contributes to poor prognosis.
Here, we report a case of TEN with extensive intestinal
involvement. A 56-year-old female was treated by zonisa-
mide for fibromyalgia. Ten days later, generalized
erythema appeared with blister, superficial punctate kerati-
tis, and severe diarrhea. Skin biopsy specimen revealed
that marked keratinocyte death. She was diagnosed with
Stevens-Johnson syndrome (SJS). In spite of methylpredni-
solone pulse therapy for three days and plasma exchange
three times, the bullous lesions spread to cover 60% of the
body surface area. She was finally diagnosed with TEN,
and treated with high-dose intravenous immunoglobulins
for three days and another methylprednisolone pulse
therapy. After these therapies, skin lesions were gradually
improved. Despite skin manifestation improvement, the
patient’s diarrhea persisted (2000ml/day), resulting in
hypoalbuminemia (0.8g/dL). Upper endoscopy revealed
extensive erosions in esophagus and duodenum. Colono-
scopy revealed multiple erosions and edematous structures
in distal ileum and colon. Biopsy specimens of ileum and
colon showed extensive mucosal detachment and granula-
tion tissues. Examinations of Clostridium difficile toxin
and cytomegalovirus antigen were negative. According to
these findings, we considered her diarrhea to be consistent
with GI lesions related in TEN. We treated her with
mucoprotective agent, total parenteral nutrition manage-
ment, albumin supplementation, and tapered systemic
corticosteroid slowly. GI symptoms were gradually
improved. Approximately 15 cases of SJS/TEN with GI
manifestations have been reported in English literature.
The mortality rate of SJS/TEN with GI manifestations is
about 45%. There is no specific treatment, and treatment
has largely been supportive. GI symptoms are often
delayed, as in our case. GI mucosal damage may result in
enteral nutrition difficulty, hypoalbuminemia, poor wound
healing and bacterial translocation. The prolonged intest-
inal lesions may be attributable to difficulties with
re-epithelization of intestinal mucosa by digestive fluid
and formation of granulation tissue. Intestinal involvement
of SJS/TEN is refractory and life-threatening complication.
Regardless of the severity of skin manifestations, we
should carefully monitor the GI symptoms.
Authors’ details
1Hokkaido University Graduate School of Medicine, Department of
Dermatology, Japan. 2Hokkaido University Graduate School of Medicine,
Department of Gastroenterology, Japan. 3JR Sapporo Hospital, Department
of Dermatology, Japan.
Published: 18 July 2014
doi:10.1186/2045-7022-4-S3-P14
Cite this article as: Nishimura et al.: A case of toxic epidermal necrolysis
with extensive intestinal involvement. Clinical and Translational Allergy
2014 4(Suppl 3):P14.
1Hokkaido University Graduate School of Medicine, Department of
Dermatology, Japan
Full list of author information is available at the end of the article
Nishimura et al. Clinical and Translational Allergy 2014, 4(Suppl 3):P14
http://www.ctajournal.com/content/4/S3/P14
© 2014 Nishimura et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
